跳至主要内容
临床试验/NCT06044064
NCT06044064尚未招募不适用

"Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD)" - A Prospective Pilot Observational Study

Asian Institute of Gastroenterology, India0 个研究点目标入组 100 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
主要终点
Incidence of PDAC at 3 years

研究概览

简要总结

To assess whether EUS (Endoscopic Ultrasound) can serve as a valuable diagnostic tool for identifying PDAC at an early stage in individuals who have recently been diagnosed with diabetes.

Purpose: To improve the rates of early detection of pancreatic cancer.

Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer that starts in the pancreas, a gland located in your abdomen. It happens when some cells in the pancreas start growing abnormally and form a cancer.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
50 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 50 years
  • Patients diagnosed with diabetes based on FBS/ PPBS/ HbA1C
  • Presence of atleast 1 FBS parameter measured in the past 6-18 months which was not > 125 mg/dl
  • END-PDAC score > 2

排除标准

  • Known or newly detected chronic pancreatitis
  • Past history of pancreatic cancer
  • History of steroid use
  • Contraindications for EUS

结局指标

主要结局

Incidence of PDAC at 3 years

时间窗: 3yrs

次要结局

  • • Incidence of PDAC at baseline • Incidence of resectable PDAC at baseline • Incidence of resectable PDAC at 3 years(baseline and 3yrs)

研究者

发起方
Asian Institute of Gastroenterology, India
申办方类型
Other
责任方
Sponsor

相似试验

"Effect of Screening Using Imaging (CT/ EUS) on... | 临床试验